Brief: Genxone Offer For Microbiome Sequencing Services Chosen As Most Favorable In Tender
17/02/2026 15:02
Feb 17 (Reuters) - Genxone SA GX1.WA: OFFER FOR MICROBIOME SEQUENCING SERVICES CHOSEN AS MOST FAVORABLE IN TENDER BY NATIONAL INSTITUTE OF GERIATRICS, RHEUMATOLOGY AND REHABILITATION GROSS VALUE OF THE OFFER IS 246,728.16 ZLOTYS Source text: ID:nEMzpMQta Further company coverage: GX1.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Genxone SA
See all newsBrief: Genxone Q2 Net Loss 0.3 Million Zlotys
Brief: Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Brief: Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
Brief: Genxone Q1 Net Loss 0.5 Million Zlotys
Brief: Genxone FY Net Loss 2.6 Million Zlotys